Phospholipid nanodisc engineering for drug delivery systems

Biotechnology Journal
Tatsuya Murakami

Abstract

Biocompatible mesoscale nanoparticles (5-100 nm in diameter) are attractive tools for drug delivery. Among them are several types of liposomes and polymer micelles already in clinical trial or use. Generally, biocompatibility of such particles is achieved by coating them with polyethylene glycol (PEG). Without PEG coating, particles are quickly trapped in the reticuloendothelial system when intravenously administered. However, recent studies have revealed several potential problems with PEG coating, including antigenicity and restriction of cellular uptake. This has motivated the development of alternative drug and gene delivery vehicles, including chemically and genetically engineered high-density lipoprotein (HDL)-like nanodiscs or "bicelles". HDL is a naturally occurring mesoscale nanoparticle that normally ferries cholesterol around in the body. Its initial "nascent" form is thought to be a simple 10 nm disc of phospholipids in a bilayer, and can be easily synthesized in vitro by mixing recombinant apoA-I proteins with various phospholipids. In this review, the use of synthetic HDL-like phospholipid nanodiscs as biocompatible drug carriers is summarized, focussing on manufacturing, size-control, drug loading and cell target...Continue Reading

References

Oct 17, 1998·Journal of Structural Biology·T H BayburtS G Sligar
Apr 20, 2001·Advanced Drug Delivery Reviews·P C RensenT J van Berkel
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·T NakanishiK Kataoka
Mar 2, 2005·Nature Reviews. Drug Discovery·Patrick Linsel-Nitschke, Alan R Tall
Nov 30, 2005·Journal of Lipid Research·Michael N OdaRobert O Ryan
Mar 1, 2006·Expert Opinion on Investigational Drugs·Marta Marchesi, Cesare R Sirtori
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Keith G NelsonRichard Titus
Oct 19, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tatsuhiro IshidaHiroshi Kiwada
Dec 26, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·K RemautS C De Smedt
Apr 3, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·XinYu WangHiroshi Kiwada
Apr 7, 2007·International Journal of Pharmaceutics·Katherine A RedmondRobert O Ryan
Apr 13, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Linda J Johnston
Jun 19, 2007·The Journal of Biological Chemistry·Abhinav NathWilliam M Atkins
Sep 18, 2007·Nature Biotechnology·Christian WolfrumMarkus Stoffel
Nov 1, 2007·Expert Opinion on Drug Delivery·Andras G LackoWalter J McConathy
Nov 6, 2007·Biochimica Et Biophysica Acta·Thanh-Son NguyenRobert O Ryan
Feb 14, 2008·Journal of Pharmaceutical Sciences·Megan TuftelandRobert O Ryan
Mar 6, 2008·Expert Opinion on Drug Delivery·Robert O Ryan
Nov 20, 2008·Biochemical and Biophysical Research Communications·Hyeon LeeMeehyein Kim
Dec 31, 2008·Biochemical and Biophysical Research Communications·David M IovannisciRobert O Ryan
May 21, 2009·Biological Chemistry·Jonas Borch, Thomas Hamann
Oct 9, 2009·The Journal of Biological Chemistry·Zhiping WuStanley L Hazen
Oct 20, 2009·FEBS Letters·Timothy H Bayburt, Stephen G Sligar
Jan 16, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ChenZahi A Fayad
Mar 6, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stephanie M GrosseStephen L Hart
Jun 23, 2010·Molecular BioSystems·Tatsuya MurakamiHiroshi Imahori
Aug 19, 2010·Bioconjugate Chemistry·Valeria SigotThomas M Jovin
Sep 8, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Mistuni GhoshRobert O Ryan
Dec 3, 2010·Journal of Nanobiotechnology·Robert O Ryan
Dec 25, 2010·ACS Nano·Daniel A BricarelloAtul N Parikh
Apr 21, 2011·Small·Daniel C BuehlerLeonard H Rome
May 12, 2011·Accounts of Chemical Research·Kenneth K NgGang Zheng

❮ Previous
Next ❯

Citations

Nov 19, 2014·Nanomedicine·Lauren R EichakerKaren A Hasty
Jun 2, 2012·Biotechnology Journal·Anthony Ho, Norio Nakatsuji
Oct 10, 2013·Biotechnology Journal·Heath E MisakShang-You Yang
Dec 30, 2014·Journal of Microencapsulation·Lisa ElviriRuggero Bettini
Oct 31, 2016·Advanced Drug Delivery Reviews·Zhong-Cheng MoGuang-Hui Yi
Jul 10, 2016·Colloids and Surfaces. B, Biointerfaces·Hiroaki KondoMinoru Nakano
Aug 17, 2016·Biochemistry·Chase A Brisbois, Jennifer C Lee
Feb 9, 2017·Chemical Reviews·Ilia G Denisov, Stephen G Sligar
Jul 30, 2015·Biomaterials Science·Tatsuya MurakamiHyungjin Kim
Feb 23, 2013·International Journal of Molecular Sciences·Samaneh MashaghiAlireza Mashaghi
Jan 8, 2020·Journal of Nanobiotechnology·Marzena SzwedKirsten Sandvig
Apr 3, 2020·Biological & Pharmaceutical Bulletin·Ryosuke Fukuda, Tatsuya Murakami
Jan 9, 2014·Bioorganicheskaia khimiia·A V SemakovIu G Molotkovskiĭ
Jan 27, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Wei HeNicholas O Fischer
Feb 5, 2021·Nanomedicine : Nanotechnology, Biology, and Medicine·Henry J PownallCorina Rosales
Sep 1, 2018·Journal of Molecular Biology·Bikash Ranjan SahooAyyalusamy Ramamoorthy
Jul 29, 2021·ACS Applied Materials & Interfaces·Hyunseok OhDae-Hyuk Kweon
Jun 11, 2019·Journal of the American Chemical Society·Stephen E HenrichC Shad Thaxton
Sep 19, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·Thirupathi RavulaAyyalusamy Ramamoorthy
Feb 27, 2018·Langmuir : the ACS Journal of Surfaces and Colloids·Yustina YusufTsyr-Yan Yu
Jun 18, 2019·Biochimica Et Biophysica Acta. Biomembranes·Hyungjin KimTatsuya Murakami

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.